These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 17234759

  • 1. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H, Sperka T, Manent J, Giovannini M, Ponta H, Herrlich P.
    Cancer Res; 2007 Jan 15; 67(2):520-7. PubMed ID: 17234759
    [Abstract] [Full Text] [Related]

  • 2. Merlin inhibits growth hormone-regulated Raf-ERKs pathways by binding to Grb2 protein.
    Lim JY, Kim H, Jeun SS, Kang SG, Lee KJ.
    Biochem Biophys Res Commun; 2006 Feb 24; 340(4):1151-7. PubMed ID: 16405865
    [Abstract] [Full Text] [Related]

  • 3. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
    Chen KC, Zhou Y, Zhang W, Lou MF.
    Mol Vis; 2007 Mar 14; 13():374-87. PubMed ID: 17392688
    [Abstract] [Full Text] [Related]

  • 4. Regulation of Son of sevenless by the membrane-actin linker protein ezrin.
    Geissler KJ, Jung MJ, Riecken LB, Sperka T, Cui Y, Schacke S, Merkel U, Markwart R, Rubio I, Than ME, Breithaupt C, Peuker S, Seifert R, Kaupp UB, Herrlich P, Morrison H.
    Proc Natl Acad Sci U S A; 2013 Dec 17; 110(51):20587-92. PubMed ID: 24297905
    [Abstract] [Full Text] [Related]

  • 5. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
    Wiederhold T, Lee MF, James M, Neujahr R, Smith N, Murthy A, Hartwig J, Gusella JF, Ramesh V.
    Oncogene; 2004 Nov 18; 23(54):8815-25. PubMed ID: 15467741
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K, Wilkes MC, Garamszegi N, Edens M, Leof EB.
    Cancer Res; 2007 Apr 15; 67(8):3673-82. PubMed ID: 17440079
    [Abstract] [Full Text] [Related]

  • 7. Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin.
    Muranen T, Grönholm M, Renkema GH, Carpén O.
    Oncogene; 2005 Feb 10; 24(7):1150-8. PubMed ID: 15580288
    [Abstract] [Full Text] [Related]

  • 8. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
    Maeda M, Matsui T, Imamura M, Tsukita S, Tsukita S.
    Oncogene; 1999 Aug 26; 18(34):4788-97. PubMed ID: 10490812
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. EPS8 and E3B1 transduce signals from Ras to Rac.
    Scita G, Nordstrom J, Carbone R, Tenca P, Giardina G, Gutkind S, Bjarnegård M, Betsholtz C, Di Fiore PP.
    Nature; 1999 Sep 16; 401(6750):290-3. PubMed ID: 10499589
    [Abstract] [Full Text] [Related]

  • 11. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
    Surace EI, Haipek CA, Gutmann DH.
    Oncogene; 2004 Jan 15; 23(2):580-7. PubMed ID: 14724586
    [Abstract] [Full Text] [Related]

  • 12. Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism.
    Lambert JM, Lambert QT, Reuther GW, Malliri A, Siderovski DP, Sondek J, Collard JG, Der CJ.
    Nat Cell Biol; 2002 Aug 15; 4(8):621-5. PubMed ID: 12134164
    [Abstract] [Full Text] [Related]

  • 13. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
    Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I, O'Bryan JP, Gupta V, Ratner N, Der CJ, Jacks T, McClatchey AI.
    Dev Cell; 2001 Jul 15; 1(1):63-72. PubMed ID: 11703924
    [Abstract] [Full Text] [Related]

  • 14. Shedding light on Merlin's wizardry.
    Okada T, You L, Giancotti FG.
    Trends Cell Biol; 2007 May 15; 17(5):222-9. PubMed ID: 17442573
    [Abstract] [Full Text] [Related]

  • 15. MAP, a protein interacting with a tumor suppressor, merlin, through the run domain.
    Lee IK, Kim KS, Kim H, Lee JY, Ryu CH, Chun HJ, Lee KU, Lim Y, Kim YH, Huh PW, Lee KH, Han SI, Jun TY, Rha HK.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):774-83. PubMed ID: 15541357
    [Abstract] [Full Text] [Related]

  • 16. Arsenite blocks growth factor induced activation of the MAP kinase cascade, upstream of Ras and downstream of Grb2-Sos.
    Doza YN, Hall-Jackson CA, Cohen P.
    Oncogene; 1998 Jul 09; 17(1):19-24. PubMed ID: 9671310
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
    Horiguchi A, Zheng R, Shen R, Nanus DM.
    Prostate; 2008 Jun 15; 68(9):975-84. PubMed ID: 18361411
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
    Grönholm M, Teesalu T, Tyynelä J, Piltti K, Böhling T, Wartiovaara K, Vaheri A, Carpén O.
    Mol Cell Neurosci; 2005 Apr 15; 28(4):683-93. PubMed ID: 15797715
    [Abstract] [Full Text] [Related]

  • 19. The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity.
    Ryu CH, Kim SW, Lee KH, Lee JY, Kim H, Lee WK, Choi BH, Lim Y, Kim YH, Lee KH, Hwang TK, Jun TY, Rha HK.
    Oncogene; 2005 Aug 11; 24(34):5355-64. PubMed ID: 16007223
    [Abstract] [Full Text] [Related]

  • 20. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin.
    Bono P, Cordero E, Johnson K, Borowsky M, Ramesh V, Jacks T, Hynes RO.
    Exp Cell Res; 2005 Aug 01; 308(1):177-87. PubMed ID: 15913605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.